KYPROLIS Trademark

Trademark Overview

On Thursday, July 8, 2010, a trademark application was filed for KYPROLIS with the United States Patent and Trademark Office. The USPTO has given the KYPROLIS trademark a serial number of 85977958. The federal status of this trademark filing is REGISTERED AND RENEWED as of Tuesday, July 11, 2023. This trademark is owned by Onyx Pharmaceuticals, Inc.. The KYPROLIS trademark is filed in the Pharmaceutical Products category with the following description:

Human pharmaceuticals for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders
kyprolis

General Information

Serial Number85977958
Word MarkKYPROLIS
Filing DateThursday, July 8, 2010
Status800 - REGISTERED AND RENEWED
Status DateTuesday, July 11, 2023
Registration Number4269909
Registration DateTuesday, January 1, 2013
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2011

Trademark Statements

Goods and ServicesHuman pharmaceuticals for use in the treatment of cancer, oncology, tumors, hematological tumors and growths, and hematological diseases and disorders

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateTuesday, July 13, 2010
Primary Code005
First Use Anywhere DateMonday, July 30, 2012
First Use In Commerce DateMonday, July 30, 2012

Trademark Owner History

Party NameOnyx Pharmaceuticals, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressThousand Oaks, CA 913201799
Party NameOnyx Pharmaceuticals, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSouth San Francisco, CA 94080
Party NameOnyx Pharmaceuticals, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressEmeryville, CA 94608

Trademark Events

Event DateEvent Description
Tuesday, July 11, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
Tuesday, July 11, 2023REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Tuesday, July 11, 2023REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Friday, July 7, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Monday, December 12, 2022TEAS SECTION 8 & 9 RECEIVED
Friday, April 29, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, April 29, 2022TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Friday, April 29, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Friday, April 29, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Saturday, January 1, 2022COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Thursday, March 7, 2019ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, March 7, 2019TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Monday, March 19, 2018NOTICE OF ACCEPTANCE OF SEC. 8 - E-MAILED
Monday, March 19, 2018REGISTERED - SEC. 8 (6-YR) ACCEPTED
Monday, March 19, 2018CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Thursday, March 1, 2018TEAS SECTION 8 RECEIVED
Monday, January 1, 2018COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Monday, October 10, 2016APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Monday, October 10, 2016TEAS CHANGE OF OWNER ADDRESS RECEIVED
Thursday, February 20, 2014ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, February 20, 2014TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, November 5, 2013TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 1, 2013REGISTERED-PRINCIPAL REGISTER
Wednesday, November 28, 2012NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, November 27, 2012LAW OFFICE REGISTRATION REVIEW COMPLETED
Tuesday, November 27, 2012ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, November 7, 2012STATEMENT OF USE PROCESSING COMPLETE
Monday, October 22, 2012USE AMENDMENT FILED
Wednesday, November 7, 2012DIVISIONAL PROCESSING COMPLETE
Monday, October 22, 2012DIVISIONAL REQUEST RECEIVED
Monday, October 22, 2012TEAS REQUEST TO DIVIDE RECEIVED
Monday, October 22, 2012TEAS STATEMENT OF USE RECEIVED
Friday, May 25, 2012NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, May 24, 2012SOU EXTENSION 2 GRANTED
Monday, May 21, 2012SOU EXTENSION 2 FILED
Monday, May 21, 2012SOU TEAS EXTENSION RECEIVED
Friday, December 9, 2011NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, December 8, 2011SOU EXTENSION 1 GRANTED
Tuesday, November 29, 2011SOU EXTENSION 1 FILED
Thursday, December 8, 2011CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, November 29, 2011SOU TEAS EXTENSION RECEIVED
Tuesday, June 14, 2011NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Thursday, May 19, 2011APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Thursday, May 19, 2011TEAS CHANGE OF OWNER ADDRESS RECEIVED
Tuesday, April 19, 2011OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2011PUBLISHED FOR OPPOSITION
Thursday, March 17, 2011LAW OFFICE PUBLICATION REVIEW COMPLETED
Thursday, March 17, 2011APPROVED FOR PUB - PRINCIPAL REGISTER
Thursday, March 17, 2011TEAS/EMAIL CORRESPONDENCE ENTERED
Thursday, March 17, 2011CORRESPONDENCE RECEIVED IN LAW OFFICE
Tuesday, March 15, 2011ASSIGNED TO LIE
Thursday, March 3, 2011TEAS RESPONSE TO OFFICE ACTION RECEIVED
Sunday, September 5, 2010NOTIFICATION OF PRIORITY ACTION E-MAILED
Sunday, September 5, 2010PRIORITY ACTION E-MAILED
Sunday, September 5, 2010PRIORITY ACTION WRITTEN
Sunday, August 29, 2010ASSIGNED TO EXAMINER
Tuesday, July 13, 2010NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Monday, July 12, 2010NEW APPLICATION ENTERED

Related Keywords

kyprolis tumors hematological growths diseases disorders oncology pharmaceuticals treatment cancer human